FibroBiologics Inc. Uncategorized Contracts & Agreements

14 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
FibroBiologics Inc.
DE
2025
Offer Letter, dated October 29, 2024, between FibroBiologics, Inc. and Robert E. Hoffman
FibroBiologics Inc.
2024
Side Letter, dated December 19, 2024, by and among FibroBiologics, Inc., GEM Global Yield LLC SCS, and GEM Yield Bahamas Limited
FibroBiologics Inc.
2024
Amendment 1 to the Intellectual Property Cross-License Agreement between SpinalCyte LLC and FibroBiologics, Inc., effective as of May 17, 2021
FibroBiologics Inc.
2024
Form of Placement Agent Agreement
FibroBiologics Inc.
NY
2024
Form of Placement Agent Agreement
FibroBiologics Inc.
NY
2024
Description of registrants securities
FibroBiologics Inc.
DE
2024
Engagement Letter between FibroBiologics, Inc. and Maxim Group LLC dated April 24, 2023
FibroBiologics Inc.
NY
2024
Agreement Regarding Right of First Negotiation dated January 20, 2023
FibroBiologics Inc.
2023
IP Transfer Agreement between SpinalCyte, LLC and FibroBiologics, LLC, dated as of May 17, 2021
FibroBiologics Inc.
2023
Intellectual Property Cross-License Agreement dated as of May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC
FibroBiologics Inc.
2023
Agreement Regarding Right of First Negotiation dated January 20, 2023
FibroBiologics Inc.
2023
IP Transfer Agreement between SpinalCyte, LLC and FibroBiologics, LLC, dated as of May 17, 2021
FibroBiologics Inc.
2023
Intellectual Property Cross-License Agreement dated as of May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC
FibroBiologics Inc.
2023